Dodick, David W.
https://orcid.org/0000-0002-9486-6790
Mayo Clinic
Atria Academy of Science and Medicine, New York, NY, United States
Citations 387
The King-Devick test (KDT) and visual contrast sensitivity test (VCS) in migraine: the effect of migraine attack on rapid eye movements and visual sensitivity (S43.004)
Starling, Amaal J. , Chiang, Chia‐Chun , Dodick, David W. , VanderPluym, Juliana H.
Neurology | December 7, 2023 | Volume: 90 | Issue: 15_supplement | Pages: No page available
Factors Associated with Acute Medication Overuse in Persons with Migraine: Results from the 2017 Migraine in America Symptoms and Treatment (MAST) Study (S43.002)
Alam, Aftab, Reed, Michael L. , Fanning, Kristina M. , Munjal, Sagar , Buse, Dawn C. , Schwedt, Todd J. , Dodick, David W. , Lipton, Richard B.
Neurology | December 7, 2023 | Volume: 90 | Issue: 15_supplement | Pages: No page available
Efficacy of Erenumab for the Treatment of Patients With Chronic Migraine With and Without Aura (S32.006)
Kudrow, David, Tepper, Stewart J. , Cheng, Sunfa , Leonardi, Dean, Lenz, Robert , Mikol, Daniel D., Ashina, Messoud , Dodick, David W. , Goadsby, Peter J. , Reuter, Uwe
Neurology | December 7, 2023 | Volume: 90 | Issue: 15_supplement | Pages: No page available
Efficacy of Two Dose Regimens of Subcutaneous Fremanezumab Versus Placebo for the Preventive Treatment of Chronic Migraine (S32.005)
Silberstein, Stephen D., Aycardi, Ernesto, Bigal, Marcelo E. , Yeung, Paul, Blankenbiller, Tricia , Grozinski‐Wolff, Melissa, Yang, Ronghua , Ma, Yuju, Dodick, David W. , Goadsby, Peter J.
Neurology | December 7, 2023 | Volume: 90 | Issue: 15_supplement | Pages: No page available
Untangling the burden of menstrual migraine from headache day frequency: Results from the 2017 Migraine in America Symptoms and Treatment (MAST) Study (S20.003)
Pavlović, Jelena , Reed, Michael L. , Fanning, Kristina M. , Munjal, Sagar , Alam, Aftab, Buse, Dawn C. , Pavlovic, Jelena M. , Schwedt, Todd J. , Dodick, David W. , Lipton, Richard B.
Neurology | December 7, 2023 | Volume: 90 | Issue: 15_supplement | Pages: No page available
Primary Results of PROMISE-1 (Prevention Of Migraine via Intravenous eptinezumab Safety and Efficacy–1) Trial: a Phase 3, Randomized, Double-blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Eptinezumab for Prevention of Frequent Episo
Saper, Joel R., Kudrow, David, Hirman, Joe, Silberstein, Stephen D., Chakhava, George, Smith, Jeff , Lipton, Richard B. , Dodick, David W.
Neurology | December 7, 2023 | Volume: 90 | Issue: 15_supplement | Pages: No page available
Erenumab Safety Among Migraine Patients Using Triptans or With Cardiovascular (CV) Risk Factors (P4.100)
Winner, Paul, Kudrow, David, Rózniecki, J, Xue, Fei , Zhang, Feng, Cheng, Sunfa , Picard, Hernàn , Mikol, Daniel D., Reuter, Uwe , Dodick, David W. , Zhang, Feng
Neurology | December 7, 2023 | Volume: 90 | Issue: 15_supplement | Pages: No page available
Efficacy Of Fremanezumab in Patients With Chronic Migraine With or Without Concomitant Use of Preventive Medication (P4.099)
Silberstein, Stephen D., Yeung, Paul, Blankenbiller, Tricia , Ning, Xiaoping , Yang, Ronghua , Ma, Yuju, Aycardi, Ernesto, Bigal, Marcelo E. , Goadsby, Peter J. , Dodick, David W.
Neurology | December 7, 2023 | Volume: 90 | Issue: 15_supplement | Pages: No page available
Efficacy and Safety of 2 Dose Regimens of Subcutaneous Administration of Fremanezumab Versus Placebo for the Preventive Treatment of Episodic Migraine (P4.093)
Aycardi, Ernesto, Bigal, Marcelo E. , Yeung, Paul, Blankenbiller, Tricia , Grozinski‐Wolff, Melissa, Yang, Ronghua , Ma, Yuju, Silberstein, Stephen D., Dodick, David W. , Goadsby, Peter J.
Neurology | December 7, 2023 | Volume: 90 | Issue: 15_supplement | Pages: No page available
Online Medical Education Improves Knowledge of Both Risk Factors for Chronification and Clinical Trial Data in Migraine (P3.147)
Ullman, Stacey, Finnegan, Thomas , Dodick, David W.
Neurology | December 7, 2023 | Volume: 90 | Issue: 15_supplement | Pages: No page available